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Abstract
One of the hallmarks of Celiac disease (CD) is intraepithelial lymphocytosis in the small
intestine. Until now, investigations to characterize the T cell subpopulations within the epithe-
lial layer have not discriminated between the heterodimeric co-receptor molecule, CD8αβ,
and the possibly immunoregulatory CD8αα homodimer molecule. Besides TCRαβ+ CD4+
cells, no other phenotypes have been shown to be gluten-reactive. Using flow cytometry on
lymphocytes from duodenal biopsies, we determined that the number of B cells (CD3- CD19
+) and the number of CD3+ CD4- CD8- double-negative (DN) T cells were elevated 6–7 fold
in children with CD. We next isolated and quantified intraepithelial lymphocytes (IELs) from
biopsies obtained from patients (both children and adults) with CD, potential CD and non-CD
controls. Flow cytometric analysis of the duodenal T cell subpopulations was performed
including the markers TCRαβ, TCRγδ, CD4, CD8α and CD8β. Proportions of γδ T cells and
CD8αβ+ cells among IELs were increased in CD patients, whereas proportions of CD4+
CD8αα+ and CD4+ single-positive T cells were decreased. Additionally, two gluten-reactive
T cell lines (TCLs) derived from CD biopsies were analyzed for changes in proportions of T
cell subsets before and after gluten stimulation. In a proliferation assay, dividing cells were
tracked with carboxyfluorescein succinimidyl ester (CFSE), and both αβ and γδ T cells prolif-
erated in response to gluten. Changes in duodenal T cell subpopulations in potential CD
patients followed the same pattern as for CD patients, but with less pronounced effect.
Introduction
Celiac disease (CD) is an immune-mediated disease that can develop in genetically predisposed
individuals following ingestion of gluten [1]. Gluten-dependent small intestinal epithelial damage
as well as presence of CD-specific antibodies in serum characterize the disorder [2]. The severity
of epithelial affection may be graded in accordance with the Marsh classification [3], which in
Oberhu¨ber’s modification [4] ranges from grade 1 to 3(a-c) based on the level of intraepithelial
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lymphocytosis, crypt hyperplasia and villous atrophy. CD is estimated to affect about 1% of the
population in western countries and appears to increase in prevalence [5–7]. About 95% percent
of CD patients have the class II human leukocyte antigen (HLA)-DQ2 [8]. Most of the remaining
patients have either HLA-DQ8 or the α or β-subunit of the DQ2 molecule [9, 10]. These antigen-
presenting molecules have high affinity for deamidated gluten peptides (DGP). The deamidation
is caused by the enzyme tissue transglutaminase (tTG), which converts neutral glutamines into
negatively charged glutamic acids [11]. Cells with ability to present antigen on HLA class II mole-
cules such as dendritic cells, macrophages, and possibly B cells, present DGP to CD4+ T cells in
the lamina propria (LP), activating them and causing an inflammatory response to gluten, and
eventually also leading to a destruction of epithelial cells by cytotoxic T cells [8, 12].
Intraepithelial lymphocytosis and the phenotypes and role of the intraepithelial lympho-
cytes (IELs) involved in the pathogenesis of CD are topics of great interest [13, 14]. The impor-
tance of gluten-reactive CD4+ Th1 cells have been appreciated for decades [15], but these
cells are thought to primarily be present in the lamina propria, hence in another anatomical
location than the IELs used by pathologists to diagnose the disease. Previously it has been dem-
onstrated that both treated as well as untreated CD patients have a low level of possibly immu-
noregulatory CD4 CD8 double-positive T cells in the small intestinal epithelium [16]. Earlier
studies found a fraction of the CD3+ intraepithelial lymphocytes (IELs), which could not be
identified as either CD4+ or CD8+ in both CD patients with active disease as well as in treated
patients [17–19]. These CD3+ CD4- CD8- cells might be γδ T cells, detection of which can be
used to support histological CD diagnosis [20]. The fraction of γδ T cells has similarly been
found elevated in CD patients with the increase persisting after years of gluten-free diet [21–
23]. Likewise, dietary gluten can activate γδ T cells in the peripheral blood of CD patients,
probably in an antigen-driven way [24]. The role in the pathogenesis of CD of these IELs has
not been established and warrants further investigation.
The conventional CD8αβ co-receptor is an essential element in the TCR:MHC class I-inter-
action to present antigen to the CD8 effector T cell. CD8 T cells can also express a homodimer
consisting of two α-chains [25], and T lymphocytes expressing two CD8α chains without the
CD8β chain are called CD8αα. Conventional CD8 and CD4 T cells are TCR αβ+ T cells that
were positively selected in the thymus. Both TCRαβ and TCRγδ T cells can express CD8αα
only [26]. The function of the CD8αα is not yet fully understood, and it may not function as a
co-receptor [27], also on CD4+ T cells. Evidence implies that the CD8αα molecule sequesters
specific molecules required for the downstream transfer of the TCR-signal [14]. Consequently,
the CD8αα-molecule indirectly represses the TCR-signal, thereby increasing the threshold for
activation through the TCR. This mechanism is thought to be an immunoregulatory mecha-
nism specific for the gut lining, where activation of pro-inflammatory IELs can impair the epi-
thelial integrity, which is essential for protection against microorganisms.
In order to investigate potentially interesting lymphocyte subtypes in the pathogenesis of
CD, we used flow cytometry to characterize B and T cell populations in duodenal biopsies
from patients with CD and compared to controls. In this study, we particularly focused on the
CD8αα-expression, or lack thereof, on TCRαβ cells, and on the phenotypes of γδ T cells. Fur-
thermore, in vitro cultured T cell lines (TCLs) showing reactivity towards gluten were investi-
gated as to which of the specified T cell subtypes proliferated after gluten-stimulation.
Materials and methods
2.1. Subjects
Biopsies were obtained from patients undergoing diagnostic upper endoscopy at the Hans
Christian Andersen’s Children Hospital or at the Department of Gastroenterology, Odense
Lymphocyte subpopulations in celiac disease
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University Hospital, Denmark. Subject characteristics are listed in Table 1, and clinical charac-
teristics of patients with celiac disease and disease controls in Table 2. All subjects had been
instructed to maintain a diet including gluten-containing products at least 6 weeks before their
diagnostic gastroscopy. To confirm or exclude a diagnosis of CD, a pathologist evaluated three
or four duodenal biopsies and at least one biopsy from the duodenal bulb from each enrolled
patient. Blood samples were obtained at the same time as the biopsies. All patients were tested
for the presence of CD-associated haplotypes HLA-DQ2 or HLA-DQ8 using either sequence-
specific-primer technique (Celiac Gene Alleles, Biodiagene) or microarray technique (EuroAr-
ray HLA-DQ2/DQ8, EuroImmun). For culturing of TCLs, only HLA-DQ2+ patients were
Table 1. Subject characteristics from the analysis of duodenal biopsies.
Patient/Sex Age Years SerologyAnti-tTG titresa HLA status DQ2/DQ8 IgA Histology Diagnose
E11/M 10 NEG DQ8 Normal Normal Non-CD
E12/F 9 NEG -/- Normal Normal Non-CD
E19/M 11 NEG DQ2/DQ8 Normal Normal Non-CD
E21/F 8 NEG -/- Normal Normal Non-CD
E32/F 64 NEG -/- Normal Normal Non-CD
E33/M 19 NEG -/- High Normal Non-CD
E34/F 62 NEG DQ8 Normal Marsh 1 Non-CD
E37/F 23 NEG DQ2 Normal Normal Non-CD
E39/F 35 NEG DQ2/DQ8 Normal Normal Non-CD
E43/M 21 POS/35 -/- High Normal Non-CD
E13/M 13 POS/22 DQ2/DQ8 Normal Normal Potential CD
E16/F 14 POS/84 DQ2/DQ8 Normal Marsh 1 Potential CD
E26/F 9 POS/78 DQ2/DQ8 Normal Normal Potential CD
E36/F 59 POS/53 DQ2 Normal Marsh 1 Potential CD
E14/M 9 POS/116 DQ2 Normal Marsh 3 CD
E15/M 12 POS/>150 DQ2 Normal Marsh 3 CD
E18/F 9 POS/34 DQ2/DQ8 Normal Marsh 3 CD
E20/F 7 POS/78 DQ8 Normal Marsh 3 CD
E22/F 15 POS/98 DQ2 Normal Marsh 3 CD
E31/F 16 POS/143 DQ2 Normal Marsh 3 CD
E38/F 28 POS/>150 -/- (Carrier of the β-subunit of DQ2.5) Normal Marsh 3 CD
E41/F 21 POS/>150 DQ2 Normal Marsh 3 CD
E42/F 17 POS/73 DQ2 Normal Marsh 3 CD
E45/F 26 POS/>150 DQ8 Normal Marsh 3 CD
E46/F 22 POS/54 DQ2 Normal Marsh 3 CD
Table 1 shows the characteristics of the 11 CD patients, 4 potential CD patients, and 10 non-CD disease controls enrolled in the study.
aCut-off value was 20 for a positive result; maximum value was 150.
doi:10.1371/journal.pone.0170270.t001
Table 2. Clinical characteristics of patients with celiac disease and disease controls.
Children (no, m/f, age range) Adults (no, m/f, age range)
Celiac disease* 6, 2/4, 7–15 y 7, 0/7, 16–62 y
Disease controls 5, 3/2, 8–13 y 5, 1/ 4, 19–64 y
*including patients with potential celiac disease
doi:10.1371/journal.pone.0170270.t002
Lymphocyte subpopulations in celiac disease
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included to fit the tissue type of the antigen-presenting HLA-DQ2+ B cells used in later prolif-
eration assays.
Patients for this study were defined as having CD if they fulfilled two criteria: 1) a biopsy-
verified Marsh II or III lesion, and 2) having the tissue-type HLA-DQ2, DQ8, or carrying
one of the chains of the HLA-DQ2 heterodimer, as the vast majority of DQ2/8 negative CD
patients carry either the α or β subunit of HLA-DQ2 [9]. Potential CD was defined as a subject
with a positive titer of anti-tTG and carrying at least one of the predisposing HLA gene vari-
ants, but with either no histological lesions (Marsh 0) or only Marsh 1 lesions (intraepithelial
lymphocytosis) [28]. Non-CD controls (children and adults) underwent an upper endoscopy
due to suspicion of upper gastrointestinal pathology, for the children the final diagnoses were
gastroesophageal reflux disease, recurrent abdominal pain, for the adults chronic diarrhea,
dyspepsia, irritable bowel syndrome. All had normal findings at endoscopy, specifically with
no CD-associated histopathology (not higher than Marsh 1), furthermore, they were required
to have negative titers of anti-tTG antibodies in serum.
2.2. T cell, B cell and NK cell (TBNK) analysis
Lymphocytes were isolated for quantitative flow cytometry. Biopsies were homogenized by
pressing them gently against a 70 μm mesh, lymphocytes were isolated by density gradient cen-
trifugation using lymphoprep (Axis-Shield, Oslo, Norway) and analyzed using the BD Multi-
test 6-color TBNK Reagent (BD Biosciences, San Jose, CA, USA) based on expression of CD3,
CD16/56, CD45, CD19, CD4, and CD8α according to the manufacturer’s instructions on a BD
FACSCanto II flow cytometer.
2.3. T cell lines
Generation of TCLs essentially followed our previously published protocol [29]. One–three
intact biopsies were incubated overnight with 0.2 mg/ml of chymotrypsine-treated gluten pep-
tides (CT-GLU) in RPMI 1640 Glutamax containing 10% human AB serum, penicillin/strep-
tomycin and 2-mercaptoethanol (10% HS/MEPS). On day 1, biopsies were gently squeezed
through a 40 μm mesh using a soft plunger and incubated for three days with 1x106 cells/ml
irradiated (50 Gy) autologous peripheral blood mononuclear cells (PBMCs) and 10% HS/
MEPS containing 10 U/ml interleukin (IL)-2 and 1 ng/ml IL-15. Fresh medium containing
IL-2 and IL-15 was added on day 4 and 5, and on day 7 TCLs received irradiated, allogenic
PBMCs and 10 U/ml PHA to stimulate all surviving cells. TCLs were stimulated with IL-2 and
IL-15 from day 9–13 and frozen when they had stopped proliferating after receiving 10% HS/
MEPS without cytokines after day 13 (usually two or three days).
2.4. T cell proliferation assay
Gluten-reactivity of the TCLs was tested in a proliferation assay. Irradiated (75 Gy) immortal-
ised B cells (VAVY cell line from International Histocompatibility Working Group, Seattle,
WA, USA) were used as HLA-DQ2+ antigen-presenting cells (APCs) and were incubated with
0.1mg/ml deamidated (transglutaminase-treated) gluten (TG-GLU) in 96-well plates over-
night. The following day, T cells were added to the wells in a T cell to APC ratio of 1:1.5. On
day 3, 3H-thymidine was added to each well in a final concentration of 1 μCi and incubated
for 16–18 hrs before harvesting of cells and measuring incorporated radioactivity on a beta-
counter. Stimulation index (SI) was calculated as mean counts per minute (CPM) in presence
of (TG-GLU) divided by mean CPM in the absence of antigen.
Lymphocyte subpopulations in celiac disease
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2.5. Carboxyfluorescein succinimidyl ester (CFSE) proliferation assay
Identification of proliferating T cell subtypes after gluten stimulation was performed by label-
ling TCLs with CellTrace (Life Technologies, Carlsbad, CA, USA), a highly permeable
fluorescent agent, which is converted intracellularly to non-lipophilic carboxyfluorescein suc-
cinimidyl esters (CFSE). For every cell division the amount of intracellular covalently bound
CFSE will be divided evenly between daughter cells [30]. T cells were re-suspended to 1x106
cells per ml in preheated phosphate buffered saline (PBS) with 0.1% bovine serum albumin
(BSA). Cells were then incubated with 2μl CellTrace solution per 2.5ml at 37˚ for 10 min. The
process was stopped by adding 5x5ml of ice cold 10% HS/MEPS and incubation on ice for 5
min. Cells were then washed twice to eliminate any excess CellTrace or unbound CFSE. Cell-
Trace proliferation assay had the same setup and length as the thymidine assay and CFSE-
labelled T cells were added to the 96-wells in the same effector T cell:APC relationship as men-
tioned earlier. For comparison of subtype fractions before and after gluten stimulation, T cell
phenotypes were analyzed prior to setup of proliferation assays. A thymidine assay was always
conducted in parallel to determine the SI at the time of flow cytometric analysis.
2.6. Preparation of lamina propria and intraepithelial lymphocytes for
flow cytometry
Biopsies were transported on ice in isotonic saline water directly from the endoscopy unit to
the lab, and were immediately incubated in 1mM dithiothreitol (DTT) at 37˚C for 20 min
to dissolve surface mucus followed by separation of IELs and lamina propria lymphocytes
(LPLs). Supernatant with possibly released IELs were sieved into a tube and stored on ice.
Biopsies were then incubated in (0.5M) ethylenediaminetetraacetic acid (EDTA) at 37˚C for 1
h to release IELs. After sieving the supernatant into the tube containing IELs, the remains of
the biopsies were incubated in collagenase, 0.5mg/ml, at 37˚ for 30 min. Supernatants were
sieved and released LPLs saved on ice.
Intraepithelial location of the IEL population was confirmed by flow cytometry using the
expression of the CD103 molecule, an integrin (αEβ7) present on the majority of IELs (>96%)
[31] which constituted 97% of the CD3+ cells in our IEL population. Contamination by LPL B
cells (CD19+) among IELs was lower than 1% (results not shown).
2.7. Flow cytometric phenotyping of T cell subsets
Prior to labelling with conjugated antibodies, samples were incubated with Fc-block (BD Bio-
science) for 10 min at RT. The following antibodies were used for phenotyping: PE-Cy5 anti-
TCRαβ (LifeTechnologies), BV421 anti-TCRδ (BD Bioscience), APC-H7 anti-CD4 (BD Bio-
science), PE anti-CD8α (BioLegend) and PE-Cy7 anti-CD8β (eBioscience). Before labelling
with antibodies, cells were fixated and permeabelized using CytoFix/CytoPerm (BD Biosci-
ence) according to instructions provided by the manufacturer. Forward and side scatters
defined a lymphocyte gate without cell doublets. The T cell population comprises TCRαβ+ and
TCRγδ+ cells, and each TCR type was defined as fractions of the T cell gate.
2.8. Statistics
Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software Inc., San
Diego California, USA). Non-parametric test for analysis of variance between groups was
done using Kruskal-Wallis one-way ANOVA with Dunnett’s modification to detect differ-
ences between non-CD controls and the CD or potential CD groups. Tests were considered
significant when the p value was <0.05.
Lymphocyte subpopulations in celiac disease
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2.9. Ethics
Adult patients and parents of the young patients gave written informed consent to the project,
which was approved by the Ethics Committee for Biomedical Research in The Region of
Southern Denmark (Project-ID: S20110043).
Results
3.1. B cells and CD4 and CD8 double negative T cell numbers are
increased in celiac disease biopsies
In order to describe the lymphocytes that participate in CD pathogenesis, we measured the
absolute numbers of lymphocyte subpopulations within each biopsy and a corresponding
blood sample using quantitative flow cytometry with counting beads (Fig 1). There was no dif-
ference in the mean total number of CD3+ lymphocytes in blood samples between non-CD
controls and CD patients (Fig 1A). In biopsies from non-CD controls, the mean total number
Fig 1. Flow cytometric quantification of lymphocyte populations in blood and duodenal biopsies.
Panels A and B: average total number of CD3+ cells in 50 μl blood (A) and in one biopsy from each patient (B).
Comparisons were made using a two-tailed unpaired Student’s t-test; error bars represent SEM; *: p<0.05;
n = 13 (non-CD controls) and 14 (CD). Panels C and D: the same samples used in Panels A and B were
analyzed for total number of subpopulations of lymphocytes in 50 μl blood (A) and in one biopsy (B) from each
patient. Black triangles: CD patients (n = 14); open triangles: non-CD controls (n = 13). Comparisons between
CD and control samples within each subpopulation were analyzed using a two-way ANOVA with Bonferroni
post-tests; error bars represent SEM; *: p<0.05. Phenotypic markers of subpopulations: SP: CD3+ (CD4+ or
CD8α+); DP: CD3+ CD4+ CD8α+; DN: CD3+ CD4- CD8α-; B cells: CD3- CD19+; NK cells: CD3- CD16/56+;
NKT cells: CD3+ CD16/56+.
doi:10.1371/journal.pone.0170270.g001
Lymphocyte subpopulations in celiac disease
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of CD3+ lymphocytes was 54,700±15,790. This number was 82% higher (99,340 ±13,860 cells)
in biopsies from CD patients (Fig 1B). There was no difference in numbers of lymphocyte sub-
populations in blood samples from the patient groups (Fig 1C). The numbers of both CD3+
CD4- CD8α- double negative (DN) T cells as well as CD3- CD19+ B cells were relatively higher
in biopsies from CD patients compared to controls (Fig 1D). The number of DN cells was
almost 6 fold higher (6,684±1,729 cells compared to 38,381±6,315 on average) corresponding
to a difference of almost 32,000 cells per biopsy. The number of B cells was also almost 6 fold
higher, but at a much lower level (1320±764 cells compared to 7709±3821 cells). The large dif-
ference in DN T cells can explain the majority (71%) of the higher number of total CD3+ lym-
phocytes in the biopsies from CD patients. There was no statistically significant difference in
CD4+ or CD8α+ single positive (SP), CD4+ CD8α+ double positive (DP) CD3+ T lymphocytes,
NK (CD16/56+, CD3-) or NKT (CD16/56+, CD3+) cells. In order to characterize subpopula-
tions of T cells further, we performed another flow cytometric study with different biopsy
donors, and included more specific phenotypic markers, particularly focusing on CD8α and β,
as well as γδ T cells.
3.2. Proportions of TCR γδ T cells are upregulated in celiac disease
In total, 25 persons participated in this part of the study, of which 11 were confirmed to have
CD, and four had potential CD, meaning positive anti-TG serology and HLA-DQ2/8 positive,
but normal or only Marsh 1 histology (Table 1). The biopsy-derived cells were separated into
intraepithelial cells (IELs) and lamina propria lymphocytes (LPLs), and analyzed by flow
cytometry. We investigated if the CD4- CD8α- DN T cells, which were higher in the whole CD
biopsies (Fig 1D), also were present in the intraepithelial layer, and further, if these cells were
belonging to the TCRγδ or αβ T cell subsets.
Indeed, in the IEL compartment, we could demonstrate that 80–85% of all DN T cells were
TCRγδ+ in both CD patients and controls (Fig 2A). When we analyzed the proportion of γδ T
cells among all IEL T cells, we found a 72% higher number of γδ T cells in CD biopsies (Fig
2B), indicating that γδ T cells are selectively recruited to the IEL compartment in CD biopsies.
3.3. The proportion of CD8αα+ cells is higher among TCRγδ than among
TCRαβ cells
Phenotypic definitions of lymphocyte subpopulations are illustrated in Fig 3 with TCRαβ used
as example; TCRγδ cells were analyzed analogously. In a comparison of IEL CD4- CD8α+
CD8β- (CD8αα+ cells), we found a striking difference between TCRαβ and TCRγδ cells. In
both CD and non-CD controls samples, CD8αα+ constituted around 1–2% of the TCRαβ
cells, whereas they constituted around 15% of the TCRγδ cells (Figs 4B and 5B). The conven-
tional CD8+ cells (CD8αβ+) also constituted approx. 15% of TCRγδ cells with no difference
between CD and non-CD controls (Fig 5C)
3.4. Proportions of IEL TCRαβ cell subpopulations are altered in CD
patients
Among IEL TCRαβ cells, CD8αβ+ cells constituted about 74% in non-CD controls and were
significantly elevated in CD patients to almost 90% (Fig 4C). Interestingly, the mean propor-
tion of CD4+ CD8α- cells was 19% in non-CD controls and only 6% in CD patients (Fig 4D).
There was also a decrease in the proportion of TCRαβ CD4+ CD8αα+ cells from around 4 to
1% in CD patients (Fig 4E). Among the other three subpopulations identified, there were no
significant differences between non-CD controls and CD patients (Fig 4A, 4B and 4F).
Lymphocyte subpopulations in celiac disease
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Fig 2. Flow cytometric analysis of intraepithelial lymphocytes. Proportions of TCRγδ+ cells among CD4-
CD8α- (DN T cells) (A). Proportions of TCRγδ+ cells among all T cells (B). Gating strategy to identify TCRγδ+
DN T cells (C): first, all non-T cells are gated out based on lack of αβ or γδ TCR, next, CD4+ and CD8a+ cells
are gated out, and the resulting population analyzed for expression of TCRδ and TCRαβ. Comparisons were
made using a two-tailed unpaired Student’s t-test; error bars represent SEM; *: p<0.05; n = 10 (non-CD
controls) and 11 (CD).
doi:10.1371/journal.pone.0170270.g002
Lymphocyte subpopulations in celiac disease
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3.5. Analysis of lamina propria lymphocytes in CD patients and controls
showed some differences and some similarities to IELs
We performed an analogous analysis of the cells in the lamina propria compartment of the
biopsies. Results from the subtypes that differed significantly between CD patients and con-
trols in the IEL, or differed significantly in the LPL compartment, are presented in Fig 6. All
other comparisons of LPL subtypes showed no significant differences between CD patients
and controls (data not shown). TCRγδ cells showed the same trend in CD patients among
LPLs (Fig 6A) as among IELs, where the increase reached statistical significance (Fig 2B). In
contrast, no trend was observed among LPLs for CD8+ cells (Fig 6B), which were elevated
among IELs (Fig 4C). The lower proportion of CD4 and CD4 CD8αα cells in CD patients
found among IELs was not found among LPLs (Fig 6C and 6D). In the LPL compartment,
TCRγδ CD4- CD8a+ CD8b+ cells were significantly increased in CD patients in accordance
with the trend among IELs. TCRγδ CD4+ CD8α- constituted a significant lower proportion in
CD patients both among IELs and LPLs.
Fig 3. Gating strategy and definition of TCRαβ+ subpopulations. The upper left dotplot defines the
lymphocytes as either TCRαβ or γδ positive. The upper right dotplot defines A: DN (CD4- CD8α-) and D: CD4
(CD4+ CD8α-); the lower left histogram defines B: CD8αα (CD4- CD8α+ CD8β-) and C: CD8 (CD4- CD8α+
CD8β+); the lower right histogram defines E: CD4 CD8αα (CD4+ CD8α+ CD8β-); and F: DP (CD4+ CD8α+
CD8β+). TCRγδ+ cells were analyzed analogously.
doi:10.1371/journal.pone.0170270.g003
Lymphocyte subpopulations in celiac disease
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3.6. Potential CD patients resemble CD patients more than non-CD
controls
Four patients fulfilled the criteria for potential CD. They had CD-associated HLA tissue types
and positive anti-TG2 in serum (relatively low titres: 22–84 U), but no crypt hyperplasia or vil-
lous atrophy (Marsh grade 0 or 1) (Table 1), and were not recommended to follow a gluten-
Fig 4. Flow cytometric analysis of intraepithelial TCRαβ subpopulations. Based on the gating and
defined subpopulations illustrated in Fig 3, each subpopulation was analyzed separately to identify differences
between CD and controls. Comparisons were made using a two-tailed unpaired Student’s t-test; error bars
represent SEM; *: p<0.05; n = 10 (non-CD controls) and 11 (CD).
doi:10.1371/journal.pone.0170270.g004
Lymphocyte subpopulations in celiac disease
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free diet. These four patients were excluded from our direct comparison of CD versus Non-
CD controls. However, it is interesting to consider whether the flow cytometric characteristics
of biopsies in the “potential CD” state resemble the normal state or the altered state of CD
biopsies. We observed that the average pattern from potential CD patients showed an interme-
diate pattern for TCRαβ cells, and for TCRγδ cells resembled the pattern from CD patients
more than non-CD controls (Fig 7).
Fig 5. Flow cytometric analysis of intraepithelial TCRγδ subpopulations. TCRγδ+ subpopulations were
analyzed in the same manner as TCRαβ subpopulations in Fig 4. Comparisons were made using a two-tailed
unpaired Student’s t-test; error bars represent SEM; *: p<0.05; n = 10 (non-CD controls) and 11 (CD).
doi:10.1371/journal.pone.0170270.g005
Lymphocyte subpopulations in celiac disease
PLOS ONE | DOI:10.1371/journal.pone.0170270 February 6, 2017 11 / 17
3.7. Both αβ T cells and γδ T cells in gluten-reactive T cell lines
proliferate in response to gluten
Two gluten-reactive TCLs from two CD patients were stimulated with gluten to determine
which T cell subpopulations would proliferate. A phenotypic characterization of the cell lines
Fig 6. Flow cytometric analysis of lamina propria TCRαβ and TCRγδ lymphocytes. Subpopulations that
differed significantly between CD patients and controls in the IEL, or differed significantly in the LPL
compartment are presented here. Comparisons were made using a two-tailed unpaired Student’s t-test; error
bars represent SEM; *: p<0.05; n = 10 (non-CD controls) and 11 (CD).
doi:10.1371/journal.pone.0170270.g006
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was performed prior to gluten stimulation (GS) and compared to contents of subtypes after
GS. Baseline compositions of the TCLs were different in proportions, but were mainly com-
posed of the same four phenotypes: For conventional TCRαβ cells: CD8αβ and CD4+ cells;
and for TCRγδ cells: either the DN phenotype or a CD8 SP phenotype. To determine if both
αβ T cells and γδ T cells proliferate in response to gluten and possibly contributed to the previ-
ously observed changes in proportions in CD biopsies, the TCL1 and the TCL2 was CFSE-
labeled prior to GS. Altogether, 10.7% of T lymphocytes had proliferated in TCL1 in response
to gluten, and for TCL2, 19.2% had proliferated in response to gluten. Proliferating cells were
divided on the basis of their TCR type. In TCL1, 7.38% of TCRαβ and 34.2% of TCRγδ cells
had proliferated. In TCL2, the percentages were 18% for TCRαβ cells and 21.9% for TCRγδ
cells.
Discussion
In the first round of experiments, we quantified lymphocyte populations in blood samples and
duodenal biopsies from patients with CD (previously un-diagnosed) and compared to biopsies
from non-CD subjects. We found that the number of B cells and the number of DN T cells
were significantly higher (6–7 fold) in patients with CD. In a second round of experiments,
we analyzed IELs and LPLs separately using an extended panel of phenotypic T cell markers.
As expected, the previously observed increase in number of DN T cells reflected an increase
in γδ T cells. We further showed that IEL T cell subtypes were altered in biopsies from CD
patients, and that potential CD patients showed a pattern more similar to CD than to non-CD
controls. Finally, both αβ T cells and γδ T cells in gluten-reactive TCLs were able to proliferate
in response to gluten.
Fig 7. Illustration of the mean flow cytometric proportions of six identified intraepithelial T cell
subpopulations. Three groups of subjects are presented: CD and non-CD as in Figs 2 and 4–6, as well as
potential CD. Potential CD subjects had CD-associated HLA tissue types and positive anti-TG2 in serum, but
no crypt hyperplasia or villous atrophy (Marsh grade 0 or 1). TCRαβ+ TCRγδ- IELs are shown in Panel A, and
TCRαβ- TCRγδ+ IELs in Panel B. n = 10 (non-CD controls), 4 (potential CD) and 11 (CD).
doi:10.1371/journal.pone.0170270.g007
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The relatively higher number of B cells is likely different from the previously reported
increase in plasma cells, since we measured CD19+ cells. The higher number of CD19+ B cells
may reflect a role of these cells in CD pathology as previously discussed [12], possibly as anti-
gen-presenting cells. By sub-classifying T cells using the CD8β-specific antibody in combina-
tion with TCR-specific antibodies, we have presented a detailed picture of T cell subpopulations
in the lamina propria and intraepithelial compartments. We found TCRαβ+CD8+ SP T cells
(conventional cytotoxic T cells) increased in proportions in CD patients as compared to non-
CD patients. This subset is thought to be the main contributors to the epithelial damage
observed in the duodenal mucosa of CD patients [32, 33].
TCRγδ+ cells are considered unconventional, and their function is supposedly in between
the adaptive and the innate immune system [14, 34]. It has long been known that numbers of
γδ T cells is increased in CD mucosa, as we also confirmed by quantitative flow cytometry. As
expected, we observed with CFSE labelling, that αβ T cells in the gluten-reactive T cell lines
proliferated in response to gluten. Interestingly, even higher proportions of γδ T cells in the
TCLs proliferated after the stimulation, suggesting that γδ T cells are directly responding to
gluten antigens, although the proliferation could also be due to indirect stimulation by secreted
cytokines from the gluten-specific αβ CD4 T cells responding to gluten. In any case, this
emphasizes that gluten-induced activation of γδ T cells (directly or indirectly) in the gut
mucosa play a potential role in the pathogenesis of CD, or, alternatively, be involved in repair
[35].
An interesting observation in our study concerning the phenotypic characterization of IELs
was the finding that the proportional changes of T cell subsets of the group of potential CD
patients seemed to follow the pattern of CD patients rather than that of non-CD patients.
Patients with potential CD do not have degenerated architecture of the epithelial mucosa, but
they may present with the relative intraepithelial lymphocytosis, termed a Marsh grade 1. The
existence of potential CD is debated [28, 36], but some of the symptomatic potential CD
patients benefit from a gluten free diet, and asymptomatic potential CD patients appear to
have a high risk of developing full-blown CD later in life [37–39]. Our results imply that poten-
tial CD in terms of lymphocyte composition in the duodenal epithelium is an intermediate
state between normal and the diseased state with epithelial damage.
Experiments in mice have indicated that in the presence of excess interleukin (IL)-15, diet-
antigen specific CD4+ IELs of the small intestine will obtain increased cytotoxic potential as a
consequence of stimulation with their cognate antigen [40]. An almost simultaneous upregula-
tion of the supposedly immunosuppressing CD8αα-homodimer was additionally induced on
the CD4+ IELs. Increased levels of IL-15 has been detected in the small intestine of CD patients
[41], leading to the hypothesis that the same mechanisms could apply to CD4 IELs in humans
with gluten as the cognate diet-antigen. We found that proportions of IEL CD4 CD8αα T cells
were decreased by 81% in CD biopsies. Whether this reflects a pathophysiologically relevant
lack of immunosuppression by these cells in CD patients leading to enhanced inflammation
remains to be established, as no studies of their cytotoxic or regulatory potential were per-
formed in the present report. Not much is known about potential cytotoxic or protective
CD4+ T cells residing within the IEL compartment of the small intestine, and this area war-
rants further investigation.
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